Unknown Digestion, Kidneys & Other Organs NIHR-supported project Lungs & Breathing
A randomized, double-blind, placebo-controlled, multicenter phase IIb study to assess the efficacy and safety of GHZ339 in patients with Moderate to Severe Atopic Dermatitis
About this grant
This summary is based on the grant title only — the full abstract was not available.
No substantive source abstract was published for this research project funded by NIHR.
Researchers
Vincent Yip (Principal Investigator)
Related Research
Grants with similar aims, by meaning.
A Phase 3 Randomized, Placebo-controlled, Double-blind Study to Assess the Efficacy and Safety of AMG 451 in Combination With Topical Corticosteroid in Adult Subjects With Moderate-to-severe Atopic Dermatitis (AD)
A Phase 3 Randomized, Placebo-Controlled, Double-Blind Study to Evaluate Upadacitinib in Combination with Topical Corticosteroids in Adolescent and Adult Subjects with Moderate to Severe Atopic Dermatitis
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-controlled, Parallel-group, Outpatient Study Evaluating the Pharmacokinetics, Efficacy, and Safety of Baricitinib in Pediatric Patients with Moderate to Severe Atopic Dermatitis
A Randomized, Double-blind, Placebo-controlled, Repeat-dose, Multicenter Trial to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of HZN-825 in Patients with Diffuse Cutaneous Systemic Sclerosis
A Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of Dupilumab Administered Concomitantly with Topical Corticosteroids in Patients, ?6 Years to <12 Years Of Age, with Severe Atopic Dermatitis
Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research. Is something wrong? Let us know